Freenome Inc.

Exact Sciences Corp. announced today encouraging data from an ongoing colorectal cancer trial showing that its blood-based test can detect advanced precancerous lesions and growing tumors. The findin

Early cancer detection test developer Freenome has completed yet another bumper financing round, this time bringing in $254m from both new and existing investors. As with prior rounds, Roche led t

COVID-19 will serve as a wake-up call about the benefits of longevity treatments, according to investor Sergey Young. "The mortality rates for people who are elderly or have the three killer diseases

The cancer diagnostics market continues to be a hot space for investors, with San Francisco start-up Freenome Inc. recently securing $160m in funds to advance its multiomics blood-testing platform f